These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22268727)

  • 1. Pain difference associated with injection of abobotulinumtoxinA reconstituted with preserved saline and preservative-free saline: a prospective, randomized, side-by-side, double-blind study.
    Allen SB; Goldenberg NA
    Dermatol Surg; 2012 Jun; 38(6):867-70. PubMed ID: 22268727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double-blind, randomized controlled trial.
    Alam M; Dover JS; Arndt KA
    Arch Dermatol; 2002 Apr; 138(4):510-4. PubMed ID: 11939813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in injection pain with botulinum toxin type B further diluted using saline with preservative: a double-blind, randomized controlled trial.
    van Laborde S; Dover JS; Moore M; Stewart B; Arndt KA; Alam M
    J Am Acad Dermatol; 2003 Jun; 48(6):875-7. PubMed ID: 12789177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased patient comfort utilizing botulinum toxin type a reconstituted with preserved versus nonpreserved saline.
    Kwiat DM; Bersani TA; Bersani A
    Ophthalmic Plast Reconstr Surg; 2004 May; 20(3):186-9. PubMed ID: 15167724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Questioning the need to use Botox within 4 hours of reconstitution: a study of fresh vs 2-week-old Botox.
    Yang GC; Chiu RJ; Gillman GS
    Arch Facial Plast Surg; 2008; 10(4):273-9. PubMed ID: 18645097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating effects of preservative-containing saline solution on pain perception during botulinum toxin type-a injections at different locations: a prospective, single-blinded, randomized controlled trial.
    Sarifakioglu N; Sarifakioglu E
    Aesthetic Plast Surg; 2005; 29(2):113-5. PubMed ID: 15815811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Split-face double-blind study comparing the onset of action of onabotulinumtoxinA and abobotulinumtoxinA.
    Yu KC; Nettar KD; Bapna S; Boscardin WJ; Maas CS
    Arch Facial Plast Surg; 2012; 14(3):198-204. PubMed ID: 22183059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical diltiazem cream versus botulinum toxin a for the treatment of chronic anal fissure: a double-blind randomized clinical trial.
    Samim M; Twigt B; Stoker L; Pronk A
    Ann Surg; 2012 Jan; 255(1):18-22. PubMed ID: 21685792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An internally controlled, double-blind comparison of the efficacy of onabotulinumtoxinA and abobotulinumtoxinA.
    Nettar KD; Yu KC; Bapna S; Boscardin J; Maas CS
    Arch Facial Plast Surg; 2011; 13(6):380-6. PubMed ID: 21690460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the clinical attributes of abobotulinumtoxinA and onabotulinumtoxinA utilizing a novel contralateral Frontalis model and the Frontalis Activity Measurement Standard.
    Nestor MS; Ablon GR
    J Drugs Dermatol; 2011 Oct; 10(10):1148-57. PubMed ID: 21968665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A two-phase, retrospective analysis evaluating efficacy of and patient satisfaction with abobotulinumtoxina used to treat dynamic facial rhytides.
    Kiripolsky MG; Peterson JD; Guiha I; Goldman MP
    Dermatol Surg; 2011 Oct; 37(10):1443-7. PubMed ID: 21649790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxinA to treat plantarflexor/invertor overactivity after stroke.
    Dunne JW; Gracies JM; Hayes M; Zeman B; Singer BJ;
    Clin Rehabil; 2012 Sep; 26(9):787-97. PubMed ID: 22308557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-center, open-label, randomized, split-face study to assess the efficacy and safety of one versus three intradermal injection sites of abobotulinumtoxinA in the treatment of lateral periocular rhytides.
    Fabi SG; Sundaram H; Guiha I; Goldman MP
    J Drugs Dermatol; 2013 Aug; 12(8):932-7. PubMed ID: 23986168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparison between intradermal injection of abobotulinumtoxinA and normal saline for face-lifting: a split-face randomized controlled trial.
    Wanitphakdeedecha R; Ungaksornpairote C; Kaewkes A; Rojanavanich V; Phothong W; Manuskiatti W
    J Cosmet Dermatol; 2016 Dec; 15(4):452-457. PubMed ID: 27647769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain sensation during intradermal injections of three different botulinum toxin preparations in different doses and dilutions.
    Kranz G; Sycha T; Voller B; Gleiss A; Schnider P; Auff E
    Dermatol Surg; 2006 Jul; 32(7):886-90. PubMed ID: 16875469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprocedural pain in shoulder arthrography: differences between using preservative-free normal saline and normal saline with benzyl alcohol as an intraarticular contrast diluent.
    Storey TF; Gilbride G; Clifford K
    AJR Am J Roentgenol; 2014 Nov; 203(5):1059-62. PubMed ID: 25341145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Needle Size on Pain Perception in Patients Treated With Botulinum Toxin Type A Injections: A Randomized Clinical Trial.
    Alam M; Geisler A; Sadhwani D; Goyal A; Poon E; Nodzenski M; Schaeffer MR; Tung R; Minkis K
    JAMA Dermatol; 2015 Nov; 151(11):1194-9. PubMed ID: 26352252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous vs intramuscular botulinum toxin: split-face randomized study.
    Gordin EA; Luginbuhl AL; Ortlip T; Heffelfinger RN; Krein H
    JAMA Facial Plast Surg; 2014; 16(3):193-8. PubMed ID: 24699554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.